DE MARTINO, ANTONIO
DE MARTINO, ANTONIO
CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab
2021-01-01 Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Signoriello, Elisabetta; Landi, Doriana; Bosa, Chiara; Vercellino, Marco; De Martino, Antonio; Missione, Rosanna; Sparaco, Maddalena; Lavorgna, Luigi; Lus, Giacomo; Bonavita, Simona
Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era
2021-01-01 Rapisarda, L.; Trimboli, M.; Fortunato, F.; De Martino, A.; Marsico, O.; Demonte, G.; Augimeri, A.; Labate, A.; Gambardella, A.
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis
2020-01-01 Pascarella, A.; De Martino, A.; Manzo, L.; Barone, S.; Valentino, P.; Bono, F.
Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis
2020-01-01 Pascarella, A.; De Martino, A.; Manzo, L.; Barone, S.; Valentino, P.; Bono, F.
Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells
2022-01-01 Abbadessa, Gianmarco; Maida, Elisabetta; Miele, Giuseppina; Lavorgna, Luigi; Marfia, Girolama Alessandra; Valentino, Paola; De Martino, Antonio; Cavalla, Paola; Bonavita, Simona
Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic
2023-01-01 Magro, G.; Barone, S.; Tosto, F.; De Martino, A.; Santange lo, D.; Manzo, L.; Pascarella, A.; Bruno, P.; Pasquale, M.; Gambardella, A.; Valentino, P.
Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab
2023-01-01 Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Vercellino, Marco; De Martino, Antonio; Simeon, Vittorio; Lavorgna, Luigi; Bonavita, Simona
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| CD19 Cell Count at Baseline Predicts B Cell Repopulation at 6 and 12 Months in Multiple Sclerosis Patients Treated with Ocrelizumab | 1-gen-2021 | Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Signoriello, Elisabetta; Landi, Doriana; Bosa, Chiara; Vercellino, Marco; De Martino, Antonio; Missione, Rosanna; Sparaco, Maddalena; Lavorgna, Luigi; Lus, Giacomo; Bonavita, Simona | |
| Facemask headache: a new nosographic entity among healthcare providers in COVID-19 era | 1-gen-2021 | Rapisarda, L.; Trimboli, M.; Fortunato, F.; De Martino, A.; Marsico, O.; Demonte, G.; Augimeri, A.; Labate, A.; Gambardella, A. | |
| Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis | 1-gen-2020 | Pascarella, A.; De Martino, A.; Manzo, L.; Barone, S.; Valentino, P.; Bono, F. | |
| Headache due to intracranial hypertension at the time of first manifestation of multiple sclerosis | 1-gen-2020 | Pascarella, A.; De Martino, A.; Manzo, L.; Barone, S.; Valentino, P.; Bono, F. | |
| Lymphopenia in Multiple Sclerosis patients treated with Ocrelizumab is associated with an effect on CD8 T cells | 1-gen-2022 | Abbadessa, Gianmarco; Maida, Elisabetta; Miele, Giuseppina; Lavorgna, Luigi; Marfia, Girolama Alessandra; Valentino, Paola; De Martino, Antonio; Cavalla, Paola; Bonavita, Simona | |
| Natalizumab wearing-off symptoms: effect of extend interval dosing during Sars-CoV-2 pandemic | 1-gen-2023 | Magro, G.; Barone, S.; Tosto, F.; De Martino, A.; Santange lo, D.; Manzo, L.; Pascarella, A.; Bruno, P.; Pasquale, M.; Gambardella, A.; Valentino, P. | |
| Previous disease-modifying treatments influence T lymphocyte kinetics in people with multiple sclerosis switching to ocrelizumab | 1-gen-2023 | Abbadessa, Gianmarco; Miele, Giuseppina; Cavalla, Paola; Valentino, Paola; Marfia, Girolama Alessandra; Vercellino, Marco; De Martino, Antonio; Simeon, Vittorio; Lavorgna, Luigi; Bonavita, Simona |